Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics.
A characteristic feature of celiac disease is the presence of circulating autoantibodies targeted against transglutaminase 2 (TG2), reputed to have a function in angiogenesis. In this study we investigated whether TG2-specific autoantibodies derived from celiac patients inhibit angiogenesis in both...
Main Authors: | Suvi Kalliokoski, Ana-Marija Sulic, Ilma R Korponay-Szabó, Zsuzsa Szondy, Rafael Frias, Mileidys Alea Perez, Stefania Martucciello, Anne Roivainen, Lauri J Pelliniemi, Carla Esposito, Martin Griffin, Daniele Sblattero, Markku Mäki, Katri Kaukinen, Katri Lindfors, Sergio Caja |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3688809?pdf=render |
Similar Items
-
Correction: Celiac Disease–Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis and in Mice by Interfering with Endothelial Cell Dynamics.
by: Suvi Kalliokoski, et al.
Published: (2014-01-01) -
Thioredoxin is involved in endothelial cell extracellular transglutaminase 2 activation mediated by celiac disease patient IgA.
by: Cristina Antonella Nadalutti, et al.
Published: (2013-01-01) -
Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits
by: Partanen Jukka, et al.
Published: (2008-02-01) -
Celiac Disease-Type Tissue Transglutaminase Autoantibody Deposits in Kidney Biopsies of Patients with IgA Nephropathy
by: Rakel Nurmi, et al.
Published: (2021-05-01) -
The microbiota as a component of the celiac disease and non-celiac gluten sensitivity
by: Lotta Nylund, et al.
Published: (2016-04-01)